Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF

Volume: 9, Issue: 8, Pages: 578 - 589
Published: Aug 1, 2021
Abstract
The goal of this study was to evaluate the effect of empagliflozin, in addition to optimal medical treatment, on epicardial adipose tissue (EAT), interstitial myocardial fibrosis, and aortic stiffness in nondiabetic patients with heart failure with reduced ejection fraction (HFrEF).Several randomized clinical trials have established the benefits of the inhibitors of the sodium-glucose cotransporter-2 receptor (SGLT2-i) in HFrEF, independent of...
Paper Details
Title
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF
Published Date
Aug 1, 2021
Volume
9
Issue
8
Pages
578 - 589
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.